Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2005 1
2006 1
2007 1
2017 1
2019 2
2022 1
2023 1

Text availability

Article attribute

Article type

Publication date

Search Results

8 results

Results by year

Filters applied: . Clear all
Page 1
Coenzyme Q10 + alpha lipoic acid for chronic COVID syndrome.
Barletta MA, Marino G, Spagnolo B, Bianchi FP, Falappone PCF, Spagnolo L, Gatti P. Barletta MA, et al. Among authors: falappone pcf. Clin Exp Med. 2023 Jul;23(3):667-678. doi: 10.1007/s10238-022-00871-8. Epub 2022 Aug 22. Clin Exp Med. 2023. PMID: 35994177 Free PMC article. Review.
Effectiveness of Certolizumab-Pegol in Rheumatoid Arthritis, Spondyloarthritis, and Psoriatic Arthritis Based on the BIOPURE Registry: Can Early Response Predict Late Outcomes?
Iannone F, Semeraro A, Carlino G, Santo L, Bucci R, Quarta L, Maruotti N, Zuccaro C, Marsico A, Falappone PCF, Mazzotta D, Cantatore FP, Muratore M, Lapadula G. Iannone F, et al. Among authors: falappone pcf. Clin Drug Investig. 2019 Jun;39(6):565-575. doi: 10.1007/s40261-019-00782-9. Clin Drug Investig. 2019. PMID: 30941736
Occult HBV infection may negatively impact on drug survival in patients with rheumatoid arthritis on treatment with a first biologic drug. An appraisal from the Biologic Apulian Registry (BIOPURE).
Carlino G, Fornaro M, Santo L, Bucci R, Semeraro A, Quarta L, D'Onofrio F, Marsico A, Zuccaro C, Falappone PC, Mazzotta D, Cantatore FP, Muratore M, Iannone F. Carlino G, et al. Among authors: falappone pc. Reumatismo. 2019 Apr 1;71(1):24-30. doi: 10.4081/reumatismo.2019.1154. Reumatismo. 2019. PMID: 30932440 Free article.
Golimumab in real-life settings: 2 Years drug survival and predictors of clinical outcomes in rheumatoid arthritis, spondyloarthritis, and psoriatic arthritis.
Iannone F, Santo L, Anelli MG, Bucci R, Semeraro A, Quarta L, D'Onofrio F, Marsico A, Carlino G, Casilli O, Cacciapaglia F, Zuccaro C, Falappone PC, Cantatore FP, Muratore M, Lapadula G. Iannone F, et al. Among authors: falappone pc. Semin Arthritis Rheum. 2017 Aug;47(1):108-114. doi: 10.1016/j.semarthrit.2017.01.008. Epub 2017 Jan 18. Semin Arthritis Rheum. 2017. PMID: 28216195
Good clinical response, remission, and predictors of remission in rheumatoid arthritis patients treated with tumor necrosis factor-alpha blockers: the GISEA study.
Mancarella L, Bobbio-Pallavicini F, Ceccarelli F, Falappone PC, Ferrante A, Malesci D, Massara A, Nacci F, Secchi ME, Manganelli S, Salaffi F, Bambara ML, Bombardieri S, Cutolo M, Ferri C, Galeazzi M, Gerli R, Giacomelli R, Grassi W, Lapadula G, Cerinic MM, Montecucco C, Trotta F, Triolo G, Valentini G, Valesini G, Ferraccioli GF; GISEA group. Mancarella L, et al. Among authors: falappone pc. J Rheumatol. 2007 Aug;34(8):1670-3. Epub 2007 Jul 1. J Rheumatol. 2007. PMID: 17611987